A rheumatoid arthritis drug can clear up psoriasis in most children, a new study finds. The report might be enough to cinch regulatory approval for the drug, etanercept, as the first systemic medication for psoriasis in youngsters.
Psoriasis results from runaway inflammation that promotes excess skin-cell growth, creating thick red patches all over the body.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.